# Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β

> **NCT05854251** · PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 20 (actual)

## Conditions studied

- Hyperinsulinemia
- PreDiabetes

## Interventions

- **DRUG:** Anakinra
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05854251
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-15
- **Primary completion:** 2024-05-17
- **Final completion:** 2024-05-17
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854251, "Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05854251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*